Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
Cencora, Inc. acquista e distribuisce prodotti farmaceutici negli Stati Uniti e a livello internazionale.
Tradotto automaticamente
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 | 2012-09-30 | 2011-09-30 | 2010-09-30 | 2009-09-30 | 2008-09-30 | 2007-09-30 | 2006-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entrate totali | $332.8B | $321.3B | $294.0B | $262.2B | $238.6B | $214.0B | $189.9B | $179.6B | $167.9B | $153.1B | $146.8B | $136.0B | $119.6B | $88.0B | $79.5B | $80.2B | $78.0B | $71.8B | $70.2B | $66.1B | $61.2B |
| Utile lordo | $12.3B | $10.1B | $8.7B | $7.8B | $7.6B | $6.3B | $4.8B | $4.5B | $4.1B | $4.1B | $3.8B | $3.2B | $2.8B | $2.3B | $2.5B | $2.4B | $2.2B | $2.0B | $1.9B | $2.2B | $2.1B |
| Margine lordo% | 3.7% | 3.2% | 3.0% | 3.0% | 3.2% | 2.9% | 2.5% | 2.5% | 2.5% | 2.7% | 2.6% | 2.4% | 2.3% | 2.6% | 3.2% | 3.0% | 2.9% | 2.8% | 2.8% | 3.3% | 3.4% |
| Risultato Operativo (EBIT) | $4.3B | $3.6B | $3.0B | $2.4B | $2.8B | $2.7B | $2.0B | $1.9B | $1.7B | $2.0B | $1.7B | $1.3B | $1.2B | $989M | $1.3B | $1.2B | $1.1B | $899M | $824M | $787M | $728M |
| Margine operativo % | 1.3% | 1.1% | 1.0% | 0.9% | 1.1% | 1.2% | 1.1% | 1.0% | 1.0% | 1.3% | 1.1% | 1.0% | 1.0% | 1.1% | 1.6% | 1.5% | 1.4% | 1.2% | 1.2% | 1.2% | 1.2% |
| Reddito netto | $2.6B | $1.6B | $1.5B | $1.7B | $1.7B | $1.5B | ($3.4B) | $855M | $1.7B | $414M | $1.4B | ($135M) | $276M | $434M | $719M | $707M | $637M | $503M | $251M | $469M | $468M |
| Margine netto% | 0.8% | 0.5% | 0.5% | 0.7% | 0.7% | 0.7% | -1.8% | 0.5% | 1.0% | 0.3% | 1.0% | -0.1% | 0.2% | 0.5% | 0.9% | 0.9% | 0.8% | 0.7% | 0.4% | 0.7% | 0.8% |
| EBITDA | $5.1B | $3.7B | $3.4B | $3.4B | $3.1B | $2.9B | ($4.7B) | $1.7B | $1.9B | $1.5B | $1.9B | $631M | $939M | $1.1B | $1.4B | $1.3B | $1.2B | $978M | $929M | $960M | $846M |
| Utile per azione (EPS) | $13.45 | $7.96 | $7.53 | $8.53 | $8.04 | $7.39 | $-16.60 | $4.04 | $7.53 | $1.87 | $6.32 | $-0.62 | $1.17 | $1.84 | $2.80 | $2.54 | $2.22 | $1.66 | $0.77 | $1.25 | $1.13 |
| Azioni in circolazione (M) | 194M | 195M | 200M | 205M | 211M | 208M | 205M | 212M | 220M | 222M | 226M | 218M | 235M | 235M | 257M | 278M | 287M | 303M | 325M | 376M | 415M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di COR. /companies/us/COR
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms